The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $109.99

Today's change+0.49 +0.45%
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $109.99

Today's change+0.49 +0.45%
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV up (U.S.)$0.49

Core Laboratories NV closed up Thursday by (U.S.)$0.49 or 0.45% to (U.S.)$109.99. Over the last five days, shares have lost 3.52% and are down 8.60% for the last year to date. This security has underperformed the S&P 500 by 38.03% during the last year.

Key company metrics

  • Open(U.S.) $110.50
  • Previous close(U.S.) $109.50
  • High(U.S.) $111.70
  • Low(U.S.) $109.19
  • Bid / Ask-- / --
  • YTD % change-8.60%
  • Volume401,065
  • Average volume (10-day)488,414
  • Average volume (1-month)462,826
  • Average volume (3-month)576,163
  • 52-week range(U.S.) $87.27 to (U.S.) $167.48
  • Beta1.27
  • Trailing P/E21.37×
  • P/E 1 year forward32.91×
  • Forward PEG1.83×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield2.00%
  • Trailing EPS(U.S.) $5.15
Updated July 2 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+22.06%

Based on its net profit margin of 22.06%, Core Laboratories NV is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue214279276268
Total other revenue--------
Total revenue214279276268
Gross profit6911010999
Total cost of revenue144169167168
Total operating expense171188187183
Selling / general / administrative13121211
Research & development--------
Depreciation / amortization7776
Interest expense (income), net operating--------
Unusual expense (income)7000
Other operating expenses, total0-100
Operating income43908984
Interest income (expense), net non-operating-2-3-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax40888781
Income after tax31676764
Income tax, total9212017
Net income31666664
Total adjustments to net income--------
Net income before extra. items31666664
Minority interest0-100
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items31666664
Inc. avail. to common incl. extra. items31666664
Diluted net income31666664
Dilution adjustment--------
Diluted weighted average shares43444445
Diluted EPS excluding extraordinary itemsvalue per share0.721.511.501.42
Dividends per sharevalue per share0.550.500.500.50
Diluted normalized EPSvalue per share0.851.511.491.42